Eledon Pharma Q3 Adj. EPS $(0.16) Beats $(0.19) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 23.81 percent increase over losses of $(0.21) per share from
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the same period last year.